"I'm just not sure that in the next six to nine months we're really going to know that GLP-1s are giving people an unfair advantage or are so risky that we need to ban them," Koller said
Everyone responds differently to glutathione IV therapy (or any wellness treatment), so check with our team at The Wellness Co
continued until disease progression, unacceptable toxicity, or up to 12 months (combination therapy) or up to 24 months (monotherapy) Other indication: select patients with Merkel cell carcinoma (Accelerated Approval) May 19, 2025 antihemophilic factor (recombinant), PEGylated-aucl (Jivi) Bayer
The phase 2 study in type 2 diabetes patients showed significant appetite reductions, but the overall weight loss was slightly lower than in the obesity-only trial (16.9% versus 24.2% at the highest doses over comparable timeframes)
When the wrong stuff takes over stubborn fat, blood sugar spikes, out-of-control cravings your whole system feels it